• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling.MicroRNA-375 通过调节细胞外信号调节激酶信号促进 3T3-L1 脂肪细胞分化。
Clin Exp Pharmacol Physiol. 2011 Apr;38(4):239-46. doi: 10.1111/j.1440-1681.2011.05493.x.
2
Persimmon tannin represses 3T3-L1 preadipocyte differentiation via up-regulating expression of miR-27 and down-regulating expression of peroxisome proliferator-activated receptor-γ in the early phase of adipogenesis.柿单宁通过在脂肪生成早期上调miR-27的表达和下调过氧化物酶体增殖物激活受体γ的表达来抑制3T3-L1前脂肪细胞分化。
Eur J Nutr. 2015 Dec;54(8):1333-43. doi: 10.1007/s00394-014-0814-9. Epub 2014 Dec 16.
3
6-gingerol inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes.6-姜酚抑制罗格列酮诱导的 3T3-L1 脂肪细胞成脂分化。
Phytother Res. 2014 Feb;28(2):187-92. doi: 10.1002/ptr.4976. Epub 2013 Mar 21.
4
Methylation of lncSHGL promotes adipocyte differentiation by regulating miR-149/Mospd3 axis.lncSHGL 的甲基化通过调节 miR-149/Mospd3 轴促进脂肪细胞分化。
Cell Cycle. 2023 Nov;22(21-22):2361-2380. doi: 10.1080/15384101.2023.2287367. Epub 2024 Jan 18.
5
Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells.硬脂烯酸(SDA)抑制 3T3-L1 细胞中的脂肪细胞分化和脂质积累。
Lipids Health Dis. 2017 Sep 25;16(1):181. doi: 10.1186/s12944-017-0574-7.
6
Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes.柴胡皂苷 A 和 D 通过 3T3-L1 脂肪细胞中的 AMPK 和 MAPK 信号通路抑制脂肪生成。
Int J Mol Sci. 2021 Oct 22;22(21):11409. doi: 10.3390/ijms222111409.
7
Plasminogen activator inhibitor-1 modulates adipocyte differentiation.纤溶酶原激活物抑制剂-1调节脂肪细胞分化。
Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E103-E113. doi: 10.1152/ajpendo.00605.2004. Epub 2005 Sep 6.
8
The chalcones cardamonin and flavokawain B inhibit the differentiation of preadipocytes to adipocytes by activating ERK.查尔酮类化合物小豆蔻明和 flavokawain B 通过激活 ERK 抑制前体脂肪细胞向脂肪细胞的分化。
Arch Biochem Biophys. 2014 Jul 15;554:44-54. doi: 10.1016/j.abb.2014.05.008. Epub 2014 May 17.
9
Prolonged induction activates Cebpα independent adipogenesis in NIH/3T3 cells.延长诱导会激活 NIH/3T3 细胞中 Cebpα 非依赖性脂肪生成。
PLoS One. 2013;8(1):e51459. doi: 10.1371/journal.pone.0051459. Epub 2013 Jan 10.
10
miR-26b Promotes 3T3-L1 Adipocyte Differentiation Through Targeting PTEN.微小RNA-26b通过靶向磷酸酶和张力蛋白同源物促进3T3-L1脂肪细胞分化。
DNA Cell Biol. 2017 Aug;36(8):672-681. doi: 10.1089/dna.2017.3712. Epub 2017 Jun 1.

引用本文的文献

1
Role of Non-Coding RNAs in White and Brown Adipose Tissue Differentiation and Development.非编码RNA在白色和棕色脂肪组织分化与发育中的作用
Noncoding RNA. 2025 Apr 29;11(3):30. doi: 10.3390/ncrna11030030.
2
MiR-21-5p enhances differentiation and mitigates oleic acid-induced lipid droplet accumulation in C2C12 myoblasts by targeting FBXO11.MiR-21-5p通过靶向FBXO11增强C2C12成肌细胞的分化并减轻油酸诱导的脂滴积累。
Anim Biosci. 2025 Jun;38(6):1279-1290. doi: 10.5713/ab.24.0665. Epub 2025 Feb 27.
3
Platelet-enriched microRNAs as novel biomarkers in atherosclerotic and cardiovascular disease patients.富含血小板的微小RNA作为动脉粥样硬化和心血管疾病患者的新型生物标志物。
ARYA Atheroscler. 2024;20(4):47-67. doi: 10.48305/arya.2024.41664.2898.
4
MicroRNAs as Epigenetic Regulators of Obesity.微小 RNA 作为肥胖的表观遗传调控因子。
Adv Exp Med Biol. 2024;1460:595-627. doi: 10.1007/978-3-031-63657-8_20.
5
The miRNA Contribution in Adipocyte Maturation.微小RNA在脂肪细胞成熟中的作用
Noncoding RNA. 2024 Jun 12;10(3):35. doi: 10.3390/ncrna10030035.
6
SNPs in microRNA seed region and impact of miR-375 in concurrent regulation of multiple lipid accumulation-related genes.miRNA 种子区 SNPs 及其对 miR-375 同时调控多个脂质蓄积相关基因的影响。
Sci Rep. 2024 May 13;14(1):10924. doi: 10.1038/s41598-024-61673-4.
7
miRNAs as Interconnectors between Obesity and Cancer.微小RNA作为肥胖与癌症之间的联系纽带
Noncoding RNA. 2024 Apr 15;10(2):24. doi: 10.3390/ncrna10020024.
8
The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome.多囊卵巢综合征发生发展及治疗过程中外泌体的生理功能与治疗潜力
Front Physiol. 2023 Nov 6;14:1279469. doi: 10.3389/fphys.2023.1279469. eCollection 2023.
9
Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseases.外泌体非编码RNA在脂肪生成和脂质代谢调控中的进展及其在相关代谢性疾病中的作用
Front Cell Dev Biol. 2023 Sep 18;11:1173904. doi: 10.3389/fcell.2023.1173904. eCollection 2023.
10
Regulation of adipogenesis by exosomal milk miRNA.外泌体乳源微小RNA对脂肪生成的调控
Rev Endocr Metab Disord. 2023 Apr;24(2):297-316. doi: 10.1007/s11154-023-09788-3. Epub 2023 Jan 24.

本文引用的文献

1
miR-375 inhibits differentiation of neurites by lowering HuD levels.miR-375 通过降低 HuD 水平来抑制神经突的分化。
Mol Cell Biol. 2010 Sep;30(17):4197-210. doi: 10.1128/MCB.00316-10. Epub 2010 Jun 28.
2
MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.微小 RNA-375 在胃癌中下调,并通过靶向 PDK1 和 14-3-3zeta 调节细胞存活。
Cancer Res. 2010 Mar 15;70(6):2339-49. doi: 10.1158/0008-5472.CAN-09-2777. Epub 2010 Mar 9.
3
microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma.微小RNA miR-27b损害人类脂肪细胞分化并靶向过氧化物酶体增殖物激活受体γ(PPARγ)。
Biochem Biophys Res Commun. 2009 Dec 11;390(2):247-51. doi: 10.1016/j.bbrc.2009.09.098. Epub 2009 Oct 2.
4
Meta-regulation: microRNA regulation of glucose and lipid metabolism.元调控:miRNA 对葡萄糖和脂代谢的调控。
Trends Endocrinol Metab. 2009 Nov;20(9):452-9. doi: 10.1016/j.tem.2009.05.007. Epub 2009 Sep 30.
5
CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.miR 谱的变化及 miR-320 在胰岛素抵抗 3T3-L1 脂肪细胞中的作用。
Clin Exp Pharmacol Physiol. 2009 Sep;36(9):e32-9. doi: 10.1111/j.1440-1681.2009.05207.x. Epub 2009 May 19.
6
A role of miR-27 in the regulation of adipogenesis.miR-27在脂肪生成调节中的作用。
FEBS J. 2009 Apr;276(8):2348-58. doi: 10.1111/j.1742-4658.2009.06967.x.
7
MicroRNA let-7 regulates 3T3-L1 adipogenesis.微小RNA let-7调控3T3-L1脂肪生成。
Mol Endocrinol. 2009 Jun;23(6):925-31. doi: 10.1210/me.2008-0298. Epub 2009 Mar 26.
8
miR-375 maintains normal pancreatic alpha- and beta-cell mass.微小RNA-375维持胰腺α细胞和β细胞的正常数量。
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5813-8. doi: 10.1073/pnas.0810550106. Epub 2009 Mar 16.
9
MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity.在脂肪生成过程中诱导产生的、加速脂肪细胞发育的微小RNA在肥胖状态下表达下调。
Diabetes. 2009 May;58(5):1050-7. doi: 10.2337/db08-1299. Epub 2009 Feb 2.
10
Effects of rosiglitazone on the proliferation of vascular smooth muscle cell induced by high glucose.罗格列酮对高糖诱导的血管平滑肌细胞增殖的影响。
Cardiovasc Drugs Ther. 2008 Dec;22(6):453-60. doi: 10.1007/s10557-008-6127-6. Epub 2008 Jul 31.

MicroRNA-375 通过调节细胞外信号调节激酶信号促进 3T3-L1 脂肪细胞分化。

MicroRNA-375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling.

机构信息

Department of Physiology, School of Medicine, Health Key Laboratory for Pharmacoproteomics of Hunan Province/Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China.

出版信息

Clin Exp Pharmacol Physiol. 2011 Apr;38(4):239-46. doi: 10.1111/j.1440-1681.2011.05493.x.

DOI:10.1111/j.1440-1681.2011.05493.x
PMID:21291493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3086632/
Abstract
  1. Adipocyte hypertrophy and hyperplasia are important processes in the development of obesity. To understand obesity and its associated diseases, it is important to elucidate the molecular mechanisms governing adipogenesis. MicroRNA-375 has been shown to inhibit differentiation of neurites, and participate in the regulation of insulin secretion and blood homeostasis. However, it is unknown whether miR-375 plays a role in adipocyte differentiation. 2. To investigate the role of miR-375 in adipocyte differentiation, we compared the miR-375 expression level between 3T3-L1 pre-adipocytes and adipocytes using miRNA microarray and quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) analysis. Furthermore, we evaluated the effects of overexpression or inhibition of miR-375 on 3T3-L1 adipocyte differentiation. 3. In the present study, we found that miR-375 expression was increased after induction of adipogenic differentiation. Overexpression of miR-375 enhanced 3T3-L1 adipocyte differentiation, as evidenced by its ability to increase mRNA levels of both CCAAT/enhancer binding protein-α (C/EBPα) and peroxisome proliferator-activated receptor-γ (PPARγ2), and induction of adipocyte fatty acid-binding protein (aP2) and triglyceride (TG) accumulation. Furthermore, we found overexpression of miR-375 suppressed phosphorylation levels of extracellular signal-regulated kinases 1/2 (ERK1/2). In contrast, anti-miR-375 increased ERK1/2 phosphorylation levels and inhibited mRNA expression of C/EBPα, PPARγ2 and aP2 in 3T3-L1 adipocyte, accompanied by decreased adipocyte differentiation. 4. Taken together, these data suggest that miR-375 promotes 3T3-L1 adipocyte differentiation, possibly through modulating the ERK-PPARγ2-aP2 pathway.
摘要
  1. 脂肪细胞肥大和增生是肥胖发生发展的重要过程。为了深入了解肥胖及其相关疾病,阐明调控脂肪生成的分子机制至关重要。miR-375 已被证实可抑制神经突分化,并参与胰岛素分泌和血液稳态的调节。然而,miR-375 是否在脂肪细胞分化中发挥作用尚不清楚。

  2. 为了研究 miR-375 在脂肪细胞分化中的作用,我们使用 miRNA 微阵列和定量实时逆转录聚合酶链反应 (qRT-PCR) 分析比较了 3T3-L1 前脂肪细胞和脂肪细胞中的 miR-375 表达水平。此外,我们评估了过表达或抑制 miR-375 对 3T3-L1 脂肪细胞分化的影响。

  3. 在本研究中,我们发现诱导脂肪生成分化后 miR-375 的表达增加。miR-375 的过表达增强了 3T3-L1 脂肪细胞分化,表现为其能够增加 CCAAT/增强子结合蛋白-α (C/EBPα) 和过氧化物酶体增殖物激活受体-γ (PPARγ2) 的 mRNA 水平,并诱导脂肪细胞脂肪酸结合蛋白 (aP2) 和甘油三酯 (TG) 的积累。此外,我们发现 miR-375 的过表达抑制了细胞外信号调节激酶 1/2 (ERK1/2) 的磷酸化水平。相反,抗 miR-375 增加了 3T3-L1 脂肪细胞中 ERK1/2 的磷酸化水平,并抑制了 C/EBPα、PPARγ2 和 aP2 的 mRNA 表达,导致脂肪细胞分化减少。

  4. 综上所述,这些数据表明 miR-375 促进了 3T3-L1 脂肪细胞分化,可能是通过调节 ERK-PPARγ2-aP2 途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/e06c2e1c3f28/nihms269513f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/4601bd5f3930/nihms269513f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/05b34b9ed5f4/nihms269513f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/c817ac18db27/nihms269513f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/57f4c6ee114c/nihms269513f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/d3a85e054f4f/nihms269513f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/e06c2e1c3f28/nihms269513f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/4601bd5f3930/nihms269513f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/05b34b9ed5f4/nihms269513f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/c817ac18db27/nihms269513f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/57f4c6ee114c/nihms269513f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/d3a85e054f4f/nihms269513f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3790/3086632/e06c2e1c3f28/nihms269513f6.jpg